PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Cognitive Science

A nasal oxytocin spray might curtail dominant behavior in psychopaths

by Eric W. Dolan
September 14, 2021
Reading Time: 3 mins read
Add as a preferred source on GoogleFollow on Google News

Scientists have uncovered preliminary evidence that oxytocin, a neurohormone that reduces stress and fosters social bonding, could help to reduce dominant behavior in psychopathic offenders. Their findings have been published in the journal Psychoneuroendocrinology.

“As a psychiatrist, I previously worked with victims of organized violence and became aware of the phenomenon of secondary psychopathization within trauma patients suffering from chronic trauma psychopathology,” said lead researcher Ronald J.P. Rijnders, a psychiatrist affiliated with the Netherlands Institute of Forensic Psychiatry and Psychology.

“After moving to forensic psychiatry, I met many primary psychopaths in the Dutch forensic observation clinic Pieter Baan Centrum. Psychopathy is an interesting phenomenon with prevalence rates of 0.5 to 1% worldwide. If these prevalence rates were to become higher within a system, the system would tend to collapse into chaos and, ultimately, war would result.”

“Such conditions pave the way to organized violence perpetrated by, especially, psychopaths, after which the likelihood of psychotraumatization of victims increases. It is this experience that leads me to believe that as a psychiatrist, one must be aware of both the effects of psychotrauma and antisocial, psychopathic behavior,” Rijnders said.

Free daily newsletter

Don’t miss the next big psychology finding

Every morning, PsyPost sends a short briefing on the most interesting new peer-reviewed research in psychology and neuroscience.

✓ Free ✓ One email a day ✓ Unsubscribe anytime

The study compared the performance of 21 psychopathic patients to 24 non-psychopathic individuals on a gaze aversion task, which assessed how long it took for participants to look away from faces with neutral, happy, or angry expressions. Previous research has indicated that more dominant individuals tend to be slower to avert their gaze from angry faces.

Psychopathic patients completed the gaze aversion task twice, once after using a nasal spray containing oxytocin and once after using a placebo nasal spray. The controls only completed the gaze aversion task once and did not use a nasal spray.

The patients were recruited from maximum security psychiatric hospitals in the Netherlands, and had completed a forensic interview known as the Hare Psychopathy Checklist–Revised. The non-psychopathic controls, on the other hand, were recruited from the hospitals’ staff and completed a non-forensic assessment of psychopathy.

“We identified psychopathic patients and compared them to normal controls (i.e., professionals without psychopathy),” Rijnders explained.

Rijnders and his team were surprised to find that psychopathic patients (after sniffing placebo) did not exhibit more dominant behavior during the gaze aversion task on average than the control group. However, severe psychopathy was positively associated with more dominant behavior. The researchers also found evidence that a single nasal spray administration of oxytocin reduced dominant behavior among patients who scored high on the Hare Psychopathy Checklist–Revised.

“Just as psychopathy is a burden on society, so can socially dominant behavior be. It takes no imagination to understand that socially dominant psychopaths are an additional burden,” Rijnders told PsyPost. “The group of psychopathic patients as a whole did not appear to score more dominantly on a computer task measuring dominance than the group of normal controls. This was not expected. However, within the group of psychopaths we did find that the higher the psychopathy score, the higher the dominance rate. Indeed, we did expect this result.”

“Nasal administration of oxytocin removed the relationship between psychopathy score and dominant behavior. This was a striking finding. Of course, further research into this relationship is needed, but we would welcome studies in which oxytocin plays a role in the treatment of psychopaths, especially the socially dominant ones among them,” Rijnders said.

The researchers noted that the mechanism behind oxytocin’s effect on psychopathic individuals is unclear and needs further investigation.

“The study group involved a group of psychopathic patients who have been in treatment in a forensic psychiatric clinic for a long time. That group cannot be compared to untreated psychopaths. Furthermore, the study group was small, so the power of the study is low,” Rijnders explained.

The study, “Sniffing submissiveness? Oxytocin administration in severe psychopathy“, was authored by Ronald J.P. Rijnders, Anouk H. Dykstra, David Terburg, Maaike M. Kempes, and Jack van Honk.

TweetSendScanShareSendPin10ShareShareShareShareShare

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • ADHD symptoms may reflect a brain shifting toward overly synchronized activity, study suggests
  • Shouting, hitting, and taking away privileges are linked to toddlers’ behavior problems across 14 countries
  • Teens with authoritarian parents tend to hold more antisocial beliefs, study finds
  • When a partner won’t apologize, anxiously attached people may hold bigger grudges
  • In strained families, extraverted parents are more likely to be cut off by their adult children

Science of Money

  • Commanding bosses may drive stressed employees to hide what they know
  • Why office gossip hurts men’s leadership prospects more than women’s
  • Why visual harmony is the most powerful tool in product design
  • For male startup founders, average looks may pay off best in the pitch room, according to new Shark Tank study
  • Why struggling with bills feels even worse when you think the economy is booming

Recent

  • How interpreting a racing heart relates to sexual functioning in men and women
  • The link between genes and kids’ IQ shifts as they grow up, large study finds
  • Women who kill their partners are often judged through “mad, bad or sad” stereotypes, review finds
  • ADHD symptoms may reflect a brain shifting toward overly synchronized activity, study suggests
  • Republicans much more likely to think Tylenol in pregnancy is tied to autism, no matter how the question is asked
  • Group therapy helps autistic teenagers navigate dating and sexuality
  • Traditional masculinity beliefs linked to sharper testosterone drops in dads caring for preschoolers
  • Shouting, hitting, and taking away privileges are linked to toddlers’ behavior problems across 14 countries
  • Human brains track who did what to whom in ways AI language models don’t, fMRI study suggests
  • Waiting to have sex linked to lower depression risk later in life

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • FAQ

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc